What question did this study set out to answer?

This research identifies driver gene alterations in NSCLC and their association with clinicopathologic characteristics.

February 2, 2026Frontiers in Genetics0 citationsOpen Access

Correction: Driver gene alterations in NSCLC patients in southern China and their correlation with clinicopathologic characteristics

LDLingna DengGuangzhou Medical University JLJinbang liNingbo University ZQZhanlong QiuGuangzhou Medical University

Key Points

This research identifies driver gene alterations in NSCLC and their association with clinicopathologic characteristics.
Analyzed genomic alterations in NSCLC patients from southern China
Examined correlations with clinicopathologic characteristics
Considered targeted therapy outcomes
Identified significant genomic alterations, such as EGFR mutations and KRAS changes
Established correlations between alterations and clinical features
Highlighted potential implications for targeted therapy in patient management

Abstract

Keywords: EGFR, genomic alterations, non-small cell lung cancer, targeted therapy, KRAS Citation: Deng L, Li J, Qiu Z and Wang Y (2026) Correction: Driver gene alterations in NSCLC patients in southern China and their correlation with clinicopathologic characteristics. Front. Genet. 17:1794164. doi: 10.3389/fgene.2026.1794164 Received: 22 January 2026; Accepted: 23 January 2026; Published: 30 January 2026. Approved by: Copyright © 2026 Deng, Li, Qiu and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. *Correspondence: Yanfen Wang, 2022695043@gzhmu.edu.cn

Ask AI

Helpful

Bookmark

View Full Paper